Context Capital Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Context Capital Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-375,000	Closed	-$45K	–	563
2022 Q3	$45K	Hold	375,000	–	–	﹤0.01%	381
2022 Q2	$41K	Hold	375,000	–	–	﹤0.01%	414
2022 Q1	$65K	Buy	+375,000	New	+$75.9K	﹤0.01%	470

Context Capital Management's ZVSAW Position: Q4 2022 in Review

Context Capital Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 375,000 shares — an estimated $45K sold.

Context Capital Management first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $65K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

Context Capital Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Context Capital Management sold 375,000 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $45K.
Context Capital Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
Context Capital Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $65K in Q1 2022.
1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Context Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.